The dual roles of A20 in cancer

Yongyu Shi1, Xinyu Wang1, Jianing Wang1

  • 1Department of Immunology and Shandong Key Laboratory of Infection and Immunity, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Cancer Letters
|May 2, 2021
PubMed

Insights

The anti-inflammatory molecule A20 has dual roles in cancer, acting as a tumor suppressor in some cancers and an oncogene in others. Its function is cancer-type dependent, impacting tumor immunity and offering therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • A20 is an anti-inflammatory molecule implicated in various human diseases, including cancers.
  • Initially identified as a tumor suppressor in B cell lymphomas, A20 exhibits complex roles in solid tumors.

Purpose of the Study:

  • To review the diverse roles of A20 across different cancer types.
  • To elucidate the cancer-type specific functions and molecular mechanisms of A20.
  • To discuss the implications of A20 in antitumor immunity and potential therapeutic strategies.

Main Methods:

  • Literature review focusing on studies investigating A20 in various human cancers.
  • Analysis of experimental data and clinical observations regarding A20's function.
  • Synthesis of information on A20's molecular mechanisms and impact on antitumor immunity.

Main Results:

  • A20 demonstrates context-dependent roles, acting as an antitumor factor in colorectal and hepatocellular carcinomas.
  • Conversely, A20 functions as an oncogene in breast, gastric cancers, and melanomas.
  • A20's role in glioma therapy is highly context-specific.

Conclusions:

  • The function of A20 is critically dependent on the cancer type, highlighting its dual role as a tumor suppressor and oncogene.
  • Understanding A20's mechanisms in different cancers is crucial for developing targeted cancer therapies.
  • Further research into A20's involvement in antitumor immunity may reveal novel therapeutic avenues.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.6K